Search

everythinglearnresearchcommunity

for

Search:↓

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

A patient with complete hair loss regrew all her hair using tofacitinib.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib may help treat severe hair loss, but more research is needed.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.